Article: Targeted Genetics Elects Nelson L. Levy, Ph.d., M.D. to Board of Directors; Fills Board Seat Previously Held by Martin P. Sutter.

SEATTLE, May 11 /PRNewswire/ -- Targeted Genetics Corporation (Nasdaq: TGEN) today announced that Nelson L. Levy, Ph.D., M.D., has been elected to its Board of Directors. Dr. Levy, 57, is currently Chairman and Chief Executive Officer of CoreTechs Corporation, a private consulting firm that focuses on the development of early stage technologies and provides consultation to the healthcare and biotechnology industries and the investment community serving them.

Previously, Dr. Levy served as President of Fujisawa Pharmaceutical Company, the North American subsidiary of Japan's third largest pharmaceutical company. Dr. Levy was responsible for all operations, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!